Futures fell after Trump said the U.S. will raise tariffs on more than $500 billion worth of Chinese imports, increasing trade tensions.Marketsread more
Clouding the G-7 gathering, which represents the world's major industrial economies, are the tit-for-tat tariffs between Washington and Beijing.Politicsread more
Hours after President Trump said Sunday he had "second thoughts" about escalating the trade war with China, the White House sought to explain his remark because it was...Politicsread more
President Donald Trump said that he would have a major trade deal with U.K. after it leaves the European Union.Politicsread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Despite Kudlow's expectations, China said on Saturday that it strongly opposes Trump's decision to levy additional tariffs on $550 billion worth of Chinese goods, and warned...Politicsread more
President Donald Trump said Sunday he was not happy after North Korea launched short-range ballistic missiles over the weekend.Politicsread more
Bryn Mawr Trust CIO Jeffrey Mills lists where to put money to work as Wall Street copes with trade war and recession jitters.Futures Nowread more
The announcement for Target also comes on the heels of a strong quarterly earnings report, where it showed it drove more people to stores and got them to spend more money...Retailread more
The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Health-care conglomerate Johnson & Johnson lost its motion to reverse a $4.7 billion jury verdict awarded to women who blamed ovarian cancer on asbestos in the company's baby powder and other talc products, a Missouri court ruled Wednesday.
In his ruling, Missouri Circuit Court Judge Rex Burlison said there was "substantial evidence" of "particularly reprehensible conduct" by J&J, saying that executives "knew of the presence of asbestos in products that they knowingly targeted for sale to mothers and babies, knew of the damage their products caused, and misrepresented the safety of these products for decades."
Shares of the company slipped 1 percent to $129 a share in afternoon trading. The stock is now down almost 13 percent so far this month, putting it on pace for its worst month since February 2009.
The company in a statement said the motion before Burlison was just a formal step before J&J could file an appeal with the Missouri appeals court.
"The same judge has denied similar motions on prior verdicts in his court that were ultimately overturned by the appellate courts. We are confident this verdict will also be overturned on appeal," J&J said in a statement.
Lawyers for the women did not immediately respond to requests for comment from Reuters.
The women and their families said decades-long use of baby powder and other cosmetic talc products caused their illness. They allege that the company knew its talc was contaminated with asbestos since at least the 1970s but failed to warn consumers about the risks. A jury in July awarded $550 million in compensatory damages and $4.14 billion in punitive damages.
Reuters reported on Friday that J&J knew for decades that asbestos, a carcinogen, was in its Baby Powder.
On Tuesday, the plaintiffs' attorney Mark Lanier said on CNBC's "Squawk Box " that the plunge in the company's stock helps his case. The $4.7 billion verdict he won for his clients is just a fraction of the more than $50 billion in market value that J&J has lost since scathing articles were published by Reuters on Friday and The New York Times over the weekend.
"It serves my purpose as a litigator to say, 'Yes, get their attention, keep driving the stock down,'" he said.
The company denies that its talc products cause cancer or that they ever contained asbestos. It says decades of studies show its talc to be safe and has successfully overturned previous talc verdicts on technical legal grounds.
The majority of the thousands of lawsuits that J&J faces involve claims that talc itself caused ovarian cancer, but a smaller number of cases allege that contaminated talc caused mesothelioma, a tissue cancer closely linked to asbestos exposure. The cases that went to trial in St. Louis effectively combine those claims by for the first time alleging asbestos-contaminated talc caused ovarian cancer.
Reuters contributed to this article.